Healthcare
Alignment Healthcare, Inc. (ALHC)
Data as of July 16, 2026
Environment story
Alignment Healthcare operates primarily as a Medicare Advantage health insurance and care management platform with minimal direct operational carbon footprint. The company does not disclose Scope 1, Scope 2, or Scope 3 emissions data, net-zero targets, or renewable energy commitments. No environmental controversies, resource depletion issues, or climate-related litigation identified in filings. The company's environmental profile is neutral rather than strong—absence of disclosure and targets results in deductions under the rubric, though absence of material environmental harm controversies prevents severe penalty.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
No disclosed initiatives on file for this pillar.
Social story
Alignment Healthcare shows mixed performance on social metrics. The company does not disclose CEO-to-median-worker pay ratio, workforce diversity percentages, turnover rates, or union standing. No documented union-suppression activities or strikes reported within the past 24 months. The company's risk factors mention competition for physicians and nurses and labor cost pressures, but no evidence of egregious labor violations or supply-chain human-rights breaches specific to ALHC operations. Absence of disclosed diversity targets and pay-equity data, combined with healthcare industry-standard labor pressures, results in moderate deductions. No documented modern slavery, forced labor, or conflict-minerals exposure identified.
Criticisms on file
No material criticisms on file for this pillar.
Disclosed initiatives
-
Care Anywhere Clinical ModelIn-house employed clinical teams providing personalized member care, internal care delivery reducing reliance on external providers.Supports member health outcomes and employment of clinical personnel.
Governance story
Alignment Healthcare's governance profile reflects moderate risk. The company does not disclose board independence percentage, share structure voting equality, or annual lobbying expenditures. No evidence of dual-class share structure or unequal voting rights identified in SEC filings. The company faces significant regulatory and compliance exposure as a government contractor under CMS Medicare Advantage contracts, including RADV audits, false claims act risks, and data integrity investigations—but no active antitrust proceedings, consumer-safety recalls, or financial-fraud SEC consent decrees are disclosed. The company's exclusive forum provision in certificate of incorporation may limit shareholder litigation rights. Risk factors heavily emphasize regulatory and audit exposure but do not indicate active major regulatory sanctions as of filing date.
Criticisms on file
-
Risk Adjustment Data Validation (RADV) Audit Exposure: CMS has initiated payment year 2018 RADV audits with expected findings issuance in mid-2026. CMS announced in May 2025 intent to audit all eligible MA contracts each payment year. Federal district court vacated CMS's 2023 RADV final rule in September 2025 on procedural grounds, creating uncertainty regarding extrapolation and FFS Adjuster methodology. Potential material overpayment recovery and penalties depending on audit findings.Source: ALHC 10-K Item 1A Risk Factors; MD&A Critical Accounting Estimates (Revenue); SEC Filing Discussion of CMS Payment Methodology Changes.
-
False Claims Act and Fraud Exposure: Company acknowledges risk of qui tam litigation and False Claims Act liability for alleged fraudulent risk adjustment or Star ratings data submissions. DOJ and HHS-OIG have increased scrutiny of Medicare Advantage insurers. Treble damages and mandatory minimum penalties apply.Source: ALHC 10-K Item 1A Risk Factors—'We may be subject to legal proceedings and litigation...'
-
CMS Contract Termination Risk: Company's CMS contracts subject to annual renewal and bid approval. Potential suspension from Medicare Advantage program, loss of contracts, or contract termination if credible evidence of false/fraudulent/abusive activities identified.Source: ALHC 10-K Item 1A Risk Factors—'As a government contractor, we risk the potential loss of CMS contracts...'
-
AI Governance and Regulatory Uncertainty: Company discloses use of machine learning and AI in AVA platform for member analysis, risk adjustment, and care management. Legal and regulatory framework for AI in healthcare evolving rapidly. Federal agencies (HHS, CMS) developing policies on AI governance. Risk of regulatory enforcement if AI governance or use practices deemed deficient.Source: ALHC 10-K Item 1A Risk Factors—'Our use of machine learning and artificial intelligence...may introduce operational, regulatory and legal risks...'
Disclosed initiatives
-
Compliance and Audit ReadinessInternal medical record reviews, risk adjustment data validation audits (RADV) preparation, and ordinary course business process audits related to coding and data submissions to CMS.Designed to mitigate regulatory penalties and payment errors; no guarantee of audit success.
These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Alignment Healthcare, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Alignment Healthcare, Inc. in the app for interactive charts and portfolio building.
Browse Companies · Methodology · Terms of Service · Privacy Policy · Back to Missionomics